Orange Book product · Generic (ANDA)
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
At a glance
Jun 05, 2001
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 05, 2001
25 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
Strength
EQ 0.05% BASE;1%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 075502
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
- 2000LOTRISONEBrand (NDA)
NDA 020010 · MERCK SHARP DOHME
- 1984LOTRISONEBrand (NDA)
NDA 018827 · ORGANON
- 2015CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 202894 · GLENMARK SPECLT
- 2005CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 076516 · FOUGERA PHARMS
- 2004CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 076493 · SUN PHARMA CANADA
- 2002CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 076002 · ACTAVIS MID ATLANTIC
- 2001CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 075673 · TARO
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
